What can platinum offer yet in the treatment of PS2 NSCLC patients? A systematic review and meta-analysis.

Randomized phase III trials showed interesting, but conflicting results, regarding the treatment of NSCLC, PS2 population. This meta-analysis aims to review all randomized trials comparing platinum-based doublets and single-agents in NSCLC PS2 patients.